An interventional study of Horizontal placement of the intraocular lens in the capsular bag and Vertical placement of the intraocular lens in the capsular bag in Cataract and Pseudophakia, sponsored by Brighton and Sussex University Hospitals NHS Trust. Completed at 1 site in United Kingdom. Open to participants aged 18 Years to 95 Years. Per ClinicalTrials.gov, last updated 2019-12-23.
Sponsored by Brighton and Sussex University Hospitals NHS Trust · Not applicable, Interventional, and Other
Usually following cataract surgery patients would expect to have normal distance vision and not require the use of distance glasses. However, in clinical practice desired vision post cataract surgery is not achieved sometimes. In such cases a piggyback lens is used to enhance the visual outcome. This lens is placed in the ciliary sulcus (space between the iris and the lens). Often this piggyback lens is not the best fit for the ciliary sulcus space and it moves. This study will be using ultrasound biomicroscopy to measure the ciliary sulcus dimensions pre and postoperatively to estimate the normal anatomy and it's variations. Patients in this study will be randomised as to which way the intraocular lens is placed in the eye (horizontally or vertically) at the time of their cataract surgery. Patients requiring cataract surgery in both eyes will be identified from the Eye Hospital at the Royal Sussex County Hospital. Patients will be in the study for up to 6 months from being identified as suitable through to the operation in the 2nd eye and a final study visit.
Study Design This is a prospective, fellow eye randomised study.
Recruitment
A sample size of 92 eyes (46 patients) was calculated. Patients will be recruited at the Sussex Eye Hospital preoperative cataract assessment clinics where they will be screened and given a patient information sheet by a member of the research team if they can be recruited. They will be allowed to take this home to discuss with their family/friends and/or GP. They will be asked if the research team could contact them in a weeks time to discuss the study and the plan for the day of their surgery (which is their next NHS visit). Patients can then agree or decline to participate in the study . If they decline, their normal NHS pathway will continue. If they accept, written informed consent will be taken on the day of surgery as well as any extra imaging required. The key points of the trial will be reiterated and the patient will be invited to ask any questions. All members of the research team are NIHR GCP trained. All research patients will undergo surgery by the same surgeon and attend for post-operative follow-up at the Sussex Eye Hospital. In addition at this visit a research appointment will be made to undertake the research scans and examinations (see details below) by an experienced member of our research team. The research team including the surgeon cannot be blinded as the obvious direction of placement of the intraocular lens will be visible during surgery and during examination.
Pre-operative appointment
Consent If the patient would like to participate they will be asked to read and sign a consent form. If the patient gives consent for their GP to be notified of their participation in the study a letter will be sent to the GP.
Standard pre-operative protocol for all NHS patients:
The assessment will continue as follows:
Surgery
All surgery will be carried out by the same surgeon (Principal Investigator) who is an experienced senior Ophthalmic Surgeon. This is to avoid any surgery-induced study biases. Surgery will be performed employing a standardized technique with aspheric monofocal intraocular lenses. The eyes will be randomized (1:1) using a dedicated computer programme prior to the start of the study to have a vertical or horizontal placement of the intraocular lens in the capsular bag. The 0 and 180 degrees will be marked on the slit lamp prior to the surgery. The axes of the IOL will be orientated in reference to the midpoint of the optic haptic junction of the IOL.
Non-standard (research)intervention post-operatively on the day of surgery:
Image taken with anterior segment ocular coherence tomography.
Standard post-operative protocol for all NHS patients at 4-6 weeks:
1,629 studies on the registry are indexed under Cataract; 235 are open to participants now.
This study's enrollment of 46 is below the median of 79 across 1,092 interventional studies indexed under Cataract.
Browse Cataract studies →Brighton and Sussex University Hospitals NHS Trust is the lead sponsor of 22 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The eyes randomised to have horizontal placement of intraocular lenses
Procedure: Horizontal placement of the intraocular lens in the capsular bag
Fellow eye receiving vertical placement of intraocular lens.
Procedure: Vertical placement of the intraocular lens in the capsular bag
The eyes will be randomized (1:1) using a dedicated computer programme prior to the start of the study to have a vertical or horizontal placement of the intraocular lens in the capsular bag. The 0 and 180 degrees will be marked on the slit lamp prior to the surgery. The axes of the IOL will be orientated in reference to the midpoint of the optic haptic junction of the IOL. the fellow eye will receive the opposite placement (horizontal or vertical) of the IOL.
The eyes will be randomized (1:1) using a dedicated computer programme prior to the start of the study to have a vertical or horizontal placement of the intraocular lens in the capsular bag. The 0 and 180 degrees will be marked on the slit lamp prior to the surgery. The axes of the IOL will be orientated in reference to the midpoint of the optic haptic junction of the IOL. the fellow eye will receive the opposite placement (horizontal or vertical) of the IOL.
Sulcus diameter versus anterior chamber dimension
Correlations between sulcus diameter and anterior chamber dimensions in the 4 axes pre and post operatively and also for the differences post and pre operatively.
Time frame: 1 month
Changes in sulcus diameter in 4 axes in eyes with vertical and horizontal placement of IOLs
Measured on UBM
Time frame: 1 month
Changes in anterior chamber depth following cataract extraction
Measured on UBM and Pentacam
Time frame: 1 month
Changes in anterior chamber diameter following cataract extraction
Measured on UBM and Pentacam
Time frame: 1 month
Rotation of the IOL in degrees from it's primary placement at 4-6 weeks at postoperative follow up.
Measured on retro-illumination photographs
Time frame: 1 month
To explore any relationship between demographics in relation to sulcus anatomy
Analysed from the demographics
Time frame: 1 month
Plan to share: No
Ran from Sep 2016 to primary completion in Jan 2019, 27 months.
Of 300 non-industry interventional studies with no phase under Cataract, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's 27 months is above that.
Counting every sponsor, half of 490 studies reached it within 17 months; a quarter within 9 and three quarters within 28.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Dec 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Brighton and Sussex University Hospitals NHS Trust